LAVA Medtech Correlations
| LVACDelisted Stock | USD 10.44 0.00 0.00% |
The current 90-days correlation between LAVA Medtech Acquisition and CF Acquisition VII is -0.15 (i.e., Good diversification). The correlation of LAVA Medtech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
LAVA Medtech Correlation With Market
Good diversification
The correlation between LAVA Medtech Acquisition and DJI is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding LAVA Medtech Acquisition and DJI in the same portfolio, assuming nothing else is changed.
LAVA |
Moving together with LAVA Stock
| 0.7 | SYM | Symbotic Upward Rally | PairCorr |
| 0.81 | SSNLF | Samsung Electronics | PairCorr |
| 0.89 | PTAIF | PT Astra International | PairCorr |
| 0.77 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.71 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.83 | HD | Home Depot | PairCorr |
| 0.84 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.65 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.83 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.68 | WMT | Walmart Aggressive Push | PairCorr |
| 0.68 | CVX | Chevron Corp Sell-off Trend | PairCorr |
Moving against LAVA Stock
| 0.71 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.7 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.7 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.58 | BKRKY | Bank Rakyat | PairCorr |
| 0.54 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.51 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.58 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.37 | PFE | Pfizer Inc Aggressive Push | PairCorr |
Related Correlations Analysis
| 0.15 | 0.24 | 0.7 | 0.77 | CLAYU | ||
| 0.15 | 0.31 | 0.25 | 0.14 | IVCPU | ||
| 0.24 | 0.31 | 0.39 | 0.44 | VBOCU | ||
| 0.7 | 0.25 | 0.39 | 0.71 | NUBI | ||
| 0.77 | 0.14 | 0.44 | 0.71 | CFFS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between LAVA Stock performing well and LAVA Medtech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LAVA Medtech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CLAYU | 0.38 | 0.20 | 0.00 | (1.36) | 0.00 | 1.43 | 4.14 | |||
| IVCPU | 0.12 | (0.03) | 0.00 | 1.85 | 0.00 | 0.00 | 4.61 | |||
| VBOCU | 0.36 | 0.00 | (0.09) | 0.11 | 0.53 | 1.33 | 5.07 | |||
| NUBI | 0.17 | 0.01 | (0.28) | (0.69) | 0.18 | 0.57 | 1.42 | |||
| CFFS | 0.10 | 0.01 | (0.46) | 0.65 | 0.00 | 0.45 | 1.08 |
LAVA Medtech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LAVA Medtech stock to make a market-neutral strategy. Peer analysis of LAVA Medtech could also be used in its relative valuation, which is a method of valuing LAVA Medtech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Still Interested in LAVA Medtech Acquisition?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.